Latest DEF 14A proxy statements

Kearny Financial Corp. submitted definitive additional materials to the SEC, related to its proxy statement under Section 14(a) of the Securities Exchange Act of 1934.

Beam Global filed an amended proxy statement to correct numerical errors in its Pay Versus Performance table ahead of the 2025 Annual Meeting of Stockholders.

Kearny Financial Corp. announced its 2025 Annual Meeting of Stockholders to be held virtually on October 21, 2025, to vote on director elections, auditor ratification, and executive compensation.

ESSA Pharma Inc. has adjourned its special meeting to approve the XenoTherapeutics acquisition, citing ongoing discussions for revised financial terms.

IB Acquisition Corp. is seeking stockholder approval to extend its deadline to complete a business combination by six months, from September 28, 2025, to March 28, 2026.

Inspirato Incorporated announced approximately $22 million in financial commitments to strengthen its capital structure ahead of the Buyerlink merger, enabling the retirement of existing senior secured convertible notes.

Augusta Gold Corp. announced a special meeting on October 20, 2025, for stockholders to vote on the proposed merger with AngloGold Ashanti (U.S.A.) Holdings Inc.

Impact BioMedical Inc. will issue 31.9 million common shares to DSS, Inc. to convert a $12 million debt, making DSS the majority common shareholder.

WK Kellogg Co has filed supplemental disclosures to its definitive proxy statement, responding to shareholder lawsuits alleging material omissions and misrepresentations regarding its proposed merger with Ferrero International S.A.

CoreCard Corporation's Board has conditionally cancelled its employee retention program, contingent on the closing of its merger with Euronet Worldwide, Inc.

Datavault AI Inc. announced stockholder approval for the issuance of up to 130.8 million shares for $12 million in convertible notes and 31 million shares for warrant exchanges, leading to significant dilution.

Talphera, Inc. has filed definitive additional proxy materials with the U.S. Securities and Exchange Commission.

Seagate Technology Holdings PLC announced its 2025 Annual General Meeting, seeking shareholder approval on director elections, executive compensation, auditor ratification, and equity plans.

Motorsport Games Inc. has filed a definitive proxy statement with the SEC, providing information for an upcoming shareholder meeting.

Evofem Biosciences anticipates stockholder approval of its merger with Aditxt at a special meeting on September 26, 2025.

Verona Pharma plc has filed a supplement to its definitive proxy statement, updating details on executive severance benefits, management arrangements, and the expiration of the HSR waiting period related to its Scheme of Arrangement.

Cycurion, Inc. stockholders approved a reverse stock split, an increase in authorized common stock, and an expanded equity incentive plan, among other corporate actions, via written consent.

Newbury Street Acquisition Corporation requests stockholder approval to extend its deadline to complete a business combination to March 25, 2026, following the termination of its merger agreement with Infinite Reality and significant prior share redemptions.

Bakkt Holdings, Inc. calls a special meeting to approve a one-time grant of 7.45 million stock options to management, aiming to align interests for long-term value creation.

Talphera, Inc. will hold its annual meeting to vote on a reverse stock split, expanded equity incentive plans, and executive compensation amidst efforts to regain Nasdaq compliance.

SES AI Corporation announced its 2025 Annual Meeting of Stockholders, detailing proposals for director election, auditor ratification, and an advisory vote on executive compensation, alongside governance updates and financial performance metrics.

Seagate Technology Holdings plc announced significant financial recovery in Fiscal Year 2025, with revenue up 39% and net income soaring to $1.5 billion, alongside key board leadership changes and equity plan updates.

Motorsport Games Inc. calls a special meeting to approve the exercise of warrants issued in a 2024 private placement, crucial for future funding.

Intensity Therapeutics, Inc. has filed definitive additional materials related to its proxy statement pursuant to Section 14(a) of the Securities Exchange Act of 1934.

Inspirato's Board of Directors has determined that Exclusive Investments' $3.15 per share cash acquisition proposal is reasonably likely to lead to a superior offer, while reaffirming its existing Buyerlink merger recommendation.

Leading proxy advisor ISS recommends DallasNews shareholders vote FOR the $15.00 per share cash merger with Hearst, citing a 242% premium.

Intensity Therapeutics, Inc. is seeking stockholder approval for a reverse stock split to meet Nasdaq's minimum bid price requirement and improve marketability.

Momentus Inc. is seeking stockholder approval for a reverse stock split and the issuance of millions of new shares to raise capital and settle debt, signaling significant financial challenges.

AlphaTime Acquisition Corp. is seeking shareholder approval to extend its deadline to complete a business combination by three months to January 4, 2026, citing insufficient time to finalize its proposed merger with HCYC Group or find an alternative.

Safe and Green Development Corporation (SG DevCo) is seeking shareholder approval for a reverse stock split, an increase in authorized shares, and an amendment to its incentive plan at its 2025 Annual Meeting.